HC Wainwright & Co. Reiterates Buy on TransCode Therapeutics, Maintains $3 Price Target

Moomoo 24/7 ·  Apr 3 12:03

HC Wainwright & Co. analyst Emily Bodnar reiterates TransCode Therapeutics (NASDAQ:RNAZ) with a Buy and maintains $3 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment